BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Liver
,
Autoimmunity
,
Doxorubicin
,
rs2300478
,
ZBTB7A
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Rebif
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
IFI27
SIGLEC1
IFI44L
SERPING1
CCL2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN
GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN
GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN
GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN
GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Multiple sclerosis patients in remission and relapse
PBMCs from multiple sclerosis patients treated with Betaferon or Rebif
Explore Curated Studies Results
Literature
Most Relevant Literature
Therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis.
Prevention and Management of Infusion-Associated Reactions in the Comparison of Alemtuzumab and Rebi…
Antibodies to interferon beta in patients with multiple sclerosis receiving CinnoVex, rebif, and bet…
The use of rebif in the Moscow Municipal Multiple Sclerosis Center].
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated mul…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Rebif® Pregnancy Registry
A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis
Rebif® Rebidose® Versus Rebiject II® Ease-of-Use
Transition to Rebif New Formulation
Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ